Clinical Trial

Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care

Study acronym: PRECEDE
Recruiting
View on ClinicalTrials.gov →
Summary
Pre-eclampsia (PE) is a pregnancy-associated syndrome of variable severity, classically defined by the combination of hypertension and proteinuria in a previously non-hypertensive or proteinuric patient. These symptoms normally resolve within 2-3 months after delivery regardless of the severity of the pre-eclampsia. Regardless of its definition, preeclampsia is associated with an increased risk of obstetric events and, for the mother, an increased risk of developing chronic kidney disease (CKD), hypertension, diabetes and cardiovascular disease in the broad sense. The relationship between preeclampsia and Chronic Kidney Disease is, however, complex and not fully understood. Investigator proposes an interventional study to identify the diagnosis of Chronic Kidney Disease in patients who have developed an episode of Preeclampsia.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-09-16; most recent amendment 2024-08-30.
Trial Details
NCT Number NCT05056701
Lead Sponsor Centre Hospitalier le Mans
Conditions Preeclampsia
Enrollment 400 participants
Start Date 2022-05-30
Primary Completion 2037-05-30 (estimated)
Study Completion 2037-05-30 (estimated)
Updated on ClinicalTrials.gov 2024-09-04